Company VolitionRX Ltd OTC Bulletin Board

Equities

VNRX

US9286611077

Biotechnology & Medical Research

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Bio Diagnostics & Testing

Inactive Instrument

Real-time Estimate Cboe BZX Other stock markets 10:29:42 2024-06-24 am EDT			5-day change	1st Jan Change
0.667 ^USD	0.00%		0.00%	0.00%

May. 14	Transcript : VolitionRx Limited, Q1 2024 Earnings Call, May 14, 2024
May. 13	VolitionRx Limited Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

VolitionRx Limited is a multi-national epigenetics company focused on advancing the science of epigenetics. The Company is dedicated to saving lives and improving outcomes for people and animals with life-altering diseases through earlier detection, as well as disease and treatment monitoring. Through its subsidiaries, it is developing and commercializing blood tests to help diagnose and monitor a range of diseases, including cancers and diseases associated with NETosis, such as sepsis. Its key pillars are Nu.Q Vet, Nu.Q NETs, Nu.Q Discover, Nu.Q Cancer and Capture-PCR. The Nu.Q Vet Cancer Test is commercially available as a cancer screening test in dogs. Nu.Q NETs is monitoring the immune system to save lives. Nu.Q Discover is a complete solution to profiling nucleosomes. Nu.Q Cancer monitoring disease progression, response to treatment and minimal residual disease. Capture-PCRTM is isolating and capturing circulating tumor-derived DNA from plasma samples for early cancer detection.

USD in Million	Weight	2023	Weight	Delta
Blood Tests 77.2 %	68.9 %	1	77.2 %	+183.64%
Service 22.6 %	30.2 %	0	22.6 %	+89.73%
Royalty 0.2 %	1.0 %	0	0.2 %	-52.97%

USD in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	0	100.0 %	1	100.0 %	+153.04%

Managers	Title	Age	Since
Cameron Reynolds CEO	Chief Executive Officer	53	11-10-05
Terig Hughes DFI	Director of Finance/CFO	54	21-01-31
Gaetan Michel COO	Chief Operating Officer	51	21-01-31
Mark Eccleston CTO	Chief Tech/Sci/R&D Officer	42	-
Jacob Micallef CTO	Chief Tech/Sci/R&D Officer	67	14-12-31
Louise Batchelor IRO	Public Communications Contact	-	16-04-13
Terry Kelly PRN	Corporate Officer/Principal	-	20-02-29
Gael Forterre PRN	Corporate Officer/Principal	43	21-01-31
Rodney Rootsaert SEC	Corporate Secretary	52	11-10-05
Nick Plummer LAW	General Counsel	-	21-10-31

Members of the board	Title	Age	Since
Cameron Reynolds CEO	Chief Executive Officer	53	11-10-05
Martin Faulkes CHM	Chairman	80	11-10-05
Guy Innes BRD	Director/Board Member	67	11-10-05
Alan Colman BRD	Director/Board Member	75	11-10-05
Edward Futcher BRD	Director/Board Member	69	16-06-22
Phillip Barnes BRD	Director/Board Member	62	19-10-08
Kim Nguyen BRD	Director/Board Member	47	21-03-24
Mickie Henshall BRD	Director/Board Member	52	22-08-14

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	82,824,476	62,857,492 ( 75.89 %)	0	75.89 %

Name	Equities	%	Valuation
Cotterford Co. Ltd. 14.49 %	12,005,332	14.49 %	8 M $
Lagoda Investment Management LP 6.125 %	5,073,242	6.125 %	4 M $
Guy Innes 2.740 %	2,269,697	2.740 %	2 M $
Martin Faulkes 2.352 %	1,947,682	2.352 %	1 M $
Cameron Reynolds 2.269 %	1,878,926	2.269 %	1 M $
Concord International, Inc. 1.217 %	1,007,718	1.217 %	711 449 $
Vanguard Global Advisers LLC 0.7681 %	636,167	0.7681 %	449 134 $
Geode Capital Management LLC 0.7454 %	617,366	0.7454 %	435 860 $
BlackRock Institutional Trust Co. NA 0.6827 %	565,408	0.6827 %	399 178 $
Jacob Micallef 0.4737 %	392,337	0.4737 %	276 990 $

VolitionRX Ltd.

1489 West Warm Springs Road Suite 110

89014, Henderson

http://www.volition.com

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Bio Diagnostics & Testing

	1st Jan change	Capi.
EXACT SCIENCES CORPORATION	-41.25%	8.28B
GUARDANT HEALTH, INC.	+10.65%	3.62B
IOVANCE BIOTHERAPEUTICS, INC.	+1.11%	2.24B
BGI GENOMICS CO., LTD.	-22.85%	1.94B
VERACYTE, INC.	-16.07%	1.72B
MARAVAI LIFESCIENCES HOLDINGS, INC.	+11.15%	962M
CAREDX, INC	+22.42%	734M
SEEGENE, INC.	-9.17%	690M
ADAPTIVE BIOTECHNOLOGIES CORPORATION	-33.06%	477M

Bio Diagnostics & Testing